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Self-assembled DNA nanostructures with chemistry-enabled
functionality are of great interest in nanobiotechnology.
Herein, chemically modified DNA nanopores are designed
to puncture cellular membranes and cause cytotoxicity. The
nanopores are assembled fromDNA oligonucleotides to form
a 2 nm-high hydrophobic belt at one terminus. The belt is
composed of charge-neutralized ethyl phosphorothioate (EP)
groups which are required to decrease cell viability. The mode
by which the pores achieve cell killing is elucidated with
confocal microscopy. This study is the first to describe the
interaction of DNA nanopores with cells. The work lays the
foundation for the future development of cytotoxic agents
with cancer type-specificity.
Chemistry can play an important role in expanding the
functional repertoire of DNA nanostructures.[1,2] Designed
nanomaterials have been developed by equipping DNA
scaffolds[2,3] with chemical linkages to spatially arrange nano-
particles,[4] fluorophores,[5] or proteins.[6] These DNA nano-
structures have been mostly applied for cell-free applications
but not for cell biology even though the latter field benefits
from nanomaterials as demonstrated with canonical nucleic
acids.[7,8]
One class of chemically modified DNA nanostructures of
potential in cell biology are membrane-spanning DNA nano-
pores. In general, engineered nanopores that facilitate trans-
membrane flux[9] can be used for cell permeabilization, drug
delivery,[10] but also biosensing.[11–13] In the latter, label-free
analytical strategy, individual molecules passing or binding
inside a nanoscale pore are detected based on the associated
changes in the ionic pore current. A wide range of analytes
can be sensed,[11,14] and DNA can be sequenced by threading
individual strands through the pore.[12,15] Nanopores have
traditionally been constructed with re-engineered or de-novo
protein scaffolds, or organic synthetic building blocks.[16]
Nanopores composed of folded DNA are the most recent
category.[17–20] Formed either by scaffold and staple strands[17]
or short oligonucleotides,[18,19] the highly negatively charged
DNA nanopores insert into hydrophobic bilayer membranes
by chemical lipid anchors, whereby cholesterol,[17] porphy-
rin,[19] and a belt of EP tags[18] were successfully tested. In light
of their established ability to span reconstituted membranes,
we postulated that the pores could be adapted and exploited
to puncture biological cell membranes. Our interest was
spiked by the prospect of rationally designing DNA nano-
structures for cell biological applications, such as gene
transfection, drug permeabilization or targeted killing of
diseased cells.
Here we examine whether a membrane-spanning DNA
nanopore can interact with cancer cells and potentially trigger
cell death (Figure 1a and b). Our nanopore was composed of
a bundle of six DNA duplexes folded from six DNA strands
(see Figure S1 in the Supporting Information). The hollow
nanobarrel has a channel width of approximately 2 nm, an
Figure 1. A membrane-spanning DNA nanopore with cytotoxic activity
and three nanostructures which serve as negative controls. a) The NP-
EP pore is a six-duplex bundle (blue) and contains a hydrophobic belt
(purple) made up of 72 ethyl phosphorothioate (EP) groups. b) NP-EP
pores insert into a cellular bilayer resulting in cell death. c) NP-P and
the two following constructs are not expected to form a pore in the
membrane. NP-P features phosphorothioate groups but no ethyl
modification. d) NP contains native phosphate groups. e) Construct
NNP with EP groups lacks three of the six strands required to generate
the six-duplex bundle nanopore. The graphical representation of NPP
is simplified, and a complete structure is shown in Figure S4. The
nanostructures are not drawn to scale.
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outer diameter of 5.5 nm, and a height of 14 nm. At the
bottom, the pore wall features a 2 nm-high hydrophobic belt
composed of 72 EP modifications for membrane insertion.
The charge-neutral EP groups replace the native negative
phosphate groups of the DNA backbone. In a previous study,
the EP belt was successfully used by placing it in the middle of
a membrane-spanning DNA nanopore.[18] In the present
report, the belt is moved to the pore terminus to further
facilitate membrane insertion.
In addition to this pore, termed NP-EP, we built three
other nanostructures to prove that the EP-belt is essential for
cytotoxic activity. These negative controls include barrel NP-
P (Figure 1c, Figure S2) which contains non-modified phos-
phorothioate groups of negative charge under our exper-
imental conditions of pH 8.0, and barrel NP with an all-native
phosphate backbone (Figure 1d, Figure S3). As a final con-
trol, we tested NNP (Figure 1e, Figure S4) which contains
half the set of EP-modified DNA strands and cannot form
a complete nanopore.
All constructs were assembled by heating and cooling an
equimolar mixture of six DNA oligonucleotides at a concen-
tration of 1 mm in PBS buffer. For the incomplete half-barrel
structure NNP, only three strands were used. The sequences
of all oligonucleotides are provided in the Supporting
Information in Table S1. The DNA strands for NP and NP-
P, respectively, were used as supplied by a commercial vendor.
By contrast, nucleic acids for barrels NP-EP and NNP were
prepared by chemically modifying phosphorothioate with
ethyl-iodide to obtain the charge-neutralized EP group
following a published procedure.[18] Accompanying polyacryl-
amide gel electrophoretic (PAGE) analysis confirmed that
treatment with ethyl iodide resulted in completely alkylated
phosphorothioate-strands (Figure S5).[18]
Several analytical techniques were applied to confirm the
successful formation of nanobarrels NP-EP, NP-P, and NP,
and construct NNP. Native agarose gel electrophoresis
demonstrated the assembly into a uniform structure. In line
with expectations, the NP and NP-P barrels migrated at the
same height while the incomplete and smaller NNP structure
moved faster (Figure 2a). Target pore NP-EP with the
hydrophobic belt formed a streaky band (Figure 2a) as
found for other hydrophobically tagged nanostructures.[17,19,21]
The streaking likely stems from the interaction with the gel
matrix but was largely avoided in sodium dodecyl sulfate
PAGE analysis resulting in a sharp band (Figure 2b). The
surprising stability of the DNA structures under these usually
denaturing conditions was achieved by running the gel at 8 8C.
The migration of assembly products at different heights
(Figure 2b) can be caused by the smaller size (NNP) or the
different chemical compositions at the terminal belt (NP).
Atomic force microscopy (AFM) analysis established the
dimensions of the nanobarrel (Figure 2c). The apparent
height of 2.4 0.5 nm (n= 20) was expected for tip-com-
pressed hollow DNA nanostructures.[22] The AFM-derived
length and width of 13.0 2.7 nm and 6.9 1.5 nm (full-
width-at-half-maximum), respectively, were in good agree-
ment with the theoretical dimensions (14 nm and 5.5 nm). The
experimental dimensions reported here are smaller than of
similarly sized pores of previous studies[18,19] because the
present AFM read-out examined densely packed barrels
(Figure 2c) which is different to the isolated structures of the
preceding reports.
We investigated whether NP-EP interacts with lipid
bilayers by monitoring the UV-melting profiles of the DNA.
Membrane insertion of the nanopores containing hydro-
phobic groups should be thermally stabilized upon bilayer
anchorage, resulting in an increase in the melting temperature
(Tm) of the DNA nanopore.
[19,23] Indeed, for NP-EP with
a hydrophobic belt the Tm increased from 42.5 0.9 8C to
47.3 2.1 8C upon addition of small unilamellar vesicles
(SUVs; Figure 2d). In contrast, Tm values for barrels NP-P
and NP lacking the hydrophobic belt were not influenced by
lipid bilayers, implying that these controls do not bind or
insert into the SUV bilayers (Table S2).
To study whether DNA nanopores interact with cellular
membranes and exert a cytotoxic effect, NP-EP and the three
DNA constructs were incubated with cervical cancer cells
(HeLa) and assayed for mitochondrial activity which is an
indicator of cell viability.[24] After incubation for 24 h, NP-EP
nanopores at a concentration of 60 mgmL1 attenuated cell
viability by 20% compared to the three non-pore forming
controls NP, NP-P and NNP (Figure 3a, 24 h; Figure S6 shows
the data for the other concentrations). The cell killing effect
of NP-EP was retained up to 72 h after nanopore incubation
(Figure S6). A decrease in cell viability of 20% at a nanopore
concentration of approximately 100 nm compares very favor-
ably with synthetic and natural small peptide-based mem-
brane disrupting agents[25] but is lower than the evolved
potency of natural protein pore-forming cytotoxins.[26–29]
To elucidate the mechanism accounting for the observed
cytotoxicity, NP-EP pores and the three controls were
Figure 2. Characterization of pores NP-EP and nanostructures NP-P,
NP, and NNP, assembled from DNA oligonucleotides. a) 1.1% native
agarose gel electrophoresis. Left: 100 bp marker (bp=base pair).
b) 12% SDS-PAGE. Left: 100 bp marker. c) AFM analysis of NP. Scale
bar 20 nm. d) UV-melting profile of NP-PE with (red) and without
(blue) SUVs.
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fluorescently labelled (Table S1) and added to cells. Charac-
terization with flow cytometry showed that NP-EP pores were
associated with cells, in line with expectations (Figure S7).
The other constructs were also cell-associated. Confocal laser
scanning microscopy established that the NP-EP pores were
distributed mainly at the cellular membrane (Figure 3b). By
contrast, the three controls were mostly internalized (Fig-
ure S8). Internalization has been observed for several other
non-membrane DNA nanoconstructs and is likely mediated
via the endosome pathway.[8] The two different types of
cellular distribution for our DNA structures indicate that NP-
EP pores target membranes while the non-membraneous
controls remain water-solubilized. Incubating cells with
higher DNA concentrations led to less uptake (Figures S7
and S8), possibly due to a higher tendency of DNA nano-
structures to aggregate.
Additional evidence for the specific interaction of the
target NP-EP nanopores with cellular membranes was
provided by fluorescence microscopy. As expected for
membrane pores, Cy3-labeled NP-EP co-localized with cell
membranes stained with CellMask Green (Figure 3c, Fig-
ure S9). As further support, insertion of NP-EP pores into in
vitro bilayers was established with nanopore recordings (data
not shown) in line with the successful electrical measurements
of two structurally closely related nanopores.[18,19]
To confirm that membrane association of NP-EP cause
cytotoxicity, we examined the short-term kinetics of cell
viability, postulating that membrane interaction with the
pore-forming nanostructures would lead to rapid cell death.
Indeed, viability assays revealed that the cytotoxic effect
occurred within an hour of nanopore addition (Figure 3a; 1 h,
NP-EP). Such fast kinetic behavior is similar to that of barrel-
forming toxins from bacteria[27,28] or eukaryotic sources.[26]
These toxins induce membrane damage by creating a trans-
membrane pore and allowing the influx/efflux of critical ions,
nutrients, and second messengers.[28,29] We are not certain
whether the cytotoxic effect of our DNA nanopore is
mediated by the same type of mechanism or by a more
general membrane perturbation. While these questions about
the mechanism will be investigated in follow-up studies, our
controls clearly demonstrate that cell death only occurs in the
combined presence of a pore and a hydrophobic belt, strongly
suggesting that membrane interaction is the reason for
cytotoxic activity.
In summary, our DNA nanopores are the first DNA
nanostructures to cause the killing of biological cells by
targeting cellular membranes. A bilayer-spanning hydropho-
bic belt composed of ethylated phosphorothioate groups on
the outside of pore with 2 nm inner width was key to achieve
cell death. The cytotoxic nanopores have the potential to be
used as novel and valuable research tools and anti-cancer
agents. Their potency could be increased by attaining cancer-
type specificity, for example, by tethering to the pore DNA
aptamers which recognize cell markers. Additionally, chem-
ical toxins such as DNA-intercalating doxorubicin may be
included to enhance the chemotoxic effect. Optionally, more
and additional hydrophobic tags may be employed to increase
membrane anchorage. Pores might also be engineered to
change their cytotoxicity in response to chemical or biochem-
ical stimuli to tune their bioactivity. We expect that DNA
nanopores can help create a new class of custom-designed
chemical tools for biology and biomedicine.
Experimental Section
Design of the DNA nanopore and the three constructs: Nano-
structures were designed using the caDNAno software.[30] Several
suggested scaffold and staple strands were terminally linked to form
a more stable structure composed of only six DNA strands (Fig-
ure S1). Using a molecular model generated with Macromodel in
combination with caDNAno, the positions for EP modification were
Figure 3. DNA nanopores (NP-EP) are selectively cytotoxic to cervical
cancer cells, compared to the three non-membrane-targeting DNA
nanostructures. a) AlamarBlue assay depicting cell viability at 24 h and
1 hour after incubation with DNA nanostructure at 60 mgmL1 final
concentration. The data represent the averages and means of three
independent experiments. ** Statistically significant; p<0.01, one-way
ANOVA corrected for multiple comparisons using Tukey’s method.
b) DNA nanopores interact with cell membranes and enter cancer
cells. Confocal microscopy images portraying cell nuclei in blue and
DNA nanopores in red. Scale bar: 20 mm. c) NP-EP nanopores co-
localize with cell membrane as shown by confocal images portraying
cells stained with CellMask Green (left) and the same cells incubated
with Cy3-labeled NP-EP pores (right). Scale bar: 50 mm.
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selected. For fluorescence imaging, two Cy3 fluorophores were
incorporated into the two non-PPT modified strands at the 5’
positions.
Synthesis of EP-modified DNA and nanopore assembly: Phos-
phorothioate DNA oligonucleotides (5 nanomoles, PAGE-purified,
IDT-DNA, Coralville, IO; Table S1) were dissolved in 90%DMFand
10% 30 mm Tris-HCl pH 8.0 (25 mL). Iodoethane (5 mL), which had
been purified by filtration over a silica gel column, was added to the
solution. The mixture was heated to 65 8C for 1.5 h in a screw-top vial,
after which the solvent was removed under reduced pressure. The
resulting dry solid was dissolved in 0.1m EDTA pH 8.0 (100 mL) by
heating to 90 8C for 5 minutes with vigorous stirring. The DNA was
desalted using a NAP-25 column (GE Healthcare). Fractions
containing DNA were identified by monitoring absorption at
260 nm and then combined and concentrated under reduced pressure
for subsequent nanopore assembly. NP-EP pores were assembled by
heating at 95 8C for 5 minutes an equimolar mixture of 4 EP-modified
and 2 native strands (Figure S1, Table S1) at 1 mm each dissolved in
PBS buffer, followed by cooling to 16 8C at a rate of 0.5 8C min1 in
a Varian Cary 300 Bio UV/Vis spectrophotometer equipped with
a Peltier cooling element. The other three constructs were assembled
in the same way using oligonucleotides with ethyl phosphorothioate
groups, phosphorothioate groups or a native backbone as detailed in
Table S1 and Figures S2–S4.
Characterization of DNA nanostructures with native and SDS gel
electrophoresis, UV spectroscopy, and atomic force microscopy: The
assembled DNA structures were analyzed under native conditions
using 1.1% agarose gel electrophoresis in standard TBE buffer
supplemented with 11 mmMgCl2 and 0.5 mm ethidium bromide, run at
70 V for 60 minutes at 8 8C. For analysis in the presence of SDS,
a 12% polyacrylamide gel with 6% stack and running buffer 25 mm
Tris pH 8.8 supplemented with 0.1% SDS. DNA (6 pmol) was mixed
with 6 mL of 6  gel loading buffer and then loaded into the wells. The
electrophoresis conditions were 160 V, 60 minutes, and 8 8C. The
bands were visualized by staining with ethidium bromide solution
followed by UV illumination. For UV melting point analysis at
260 nm, samples with a concentration of 75 nm dissolved in 0.3m KCl,
15 mm Tris pH 8.0 were heated at a rate of 1 8C per minute in the
spectrophotometer. Melting analysis with small unilamellar vesicles
(SUVs) was carried out at a molar ratio of 0.1 to 500 for nanopores to
SUV lipid. The vesicles were prepared by sonication of a lipid
solution containing DPhPC and cholesterol. DPhPC (11.1 mM,
2.65 mL) was added to cholesterol (10 mM, 0.295 mL) in a 20 mL
round bottom flask. The solution was dried under vacuum using
a rotary evaporator for 30 minutes, followed by an additional 4 hours
under ultrahigh vacuum. Deionized water (500 mL) was added to the
thin film, and the suspension was sonicated for 10–20 minutes. The
SUVs with a size range of 50–100 nm, as determined by dynamic light
scattering, were stored at 4 8C for up to a week. AFM analysis was
carried out by first adsorbing NP DNA barrels onto mica following
a modified version of a published procedure.[31] Freshly cleaved mica
was incubated with a solution of 150 mm KCl and 7.5 mm Tris pH 8.0.
The DNA-barrel solution was added to give a final DNA concen-
tration of 20 nm. AFM topographical images were acquired in situ at
RTwith a multimode atomic force microscope as described.[18]
Cell culture: Human cervical cancer cells (HeLa cells) were
a kind gift from Prof. Charles Swanton (UCL, UK). Cells were grown
in Dulbeccos modified Eagle Medium (DMEM) supplemented with
10% heat inactivated fetal bovine serum, 50 mgmL1 streptomycin,
and 50 IU mL1 penicillin. Cells were passaged regularly when
reaching 80% confluence.
Cell viability: HeLa cells were seeded at a density of 1500 cells
per well, in a 96 well plate. After 24 h, DNA nanostructures were
incubated with cells at the desired concentrations in triplicate. At the
chosen time-points, the AlamarBlue reagent was added to cells for
2 1=2 h, as recommended by the manufacturers guidelines.
[24] Absorb-
ance readings were recorded and normalized to those of untreated
control cells.
Live cell imaging: HeLa cells were plated at a density of 15000
cells per well, in an ibidi chamber slide (Vitaris, France). The
following day, Cy3-labeled DNA nanostructures were added to cells
at the desired concentrations. After incubation at 37 8C for 3 h, cells
were washed three times with DMEM to remove non-internalized
DNA. For staining of cellular nuclei, a solution of Hoechst 33258
pentahydrate was added to a final concentration of 3 mgmL1
followed by incubation for 20 minutes at 37 8C. Cells were washed
and supplanted with fresh media prior to imaging on a LSM 700
inverted confocal microscope (Carl Zeiss, Germany). Imaging was
achieved using a 63  objective lens and laser excitations of 405 nm
(Hoechst channel) and 555 nm (Cy3 channel).
Flow cytometry: HeLa cells were plated in duplicate at a density
of 45000 cells per well in a 24 well plate. After 24 h, cells were
incubated with DNA structures at the desired concentration at 37 8C
for 3 h. Cells were washed three times with media and once with PBS,
and harvested by centrifugation at 300 g for 5 minutes. Supernatants
were discarded and cells were resuspended in fresh media and filtered
into FACS tubes (BD Biosciences, USA). 10000 live events were
recorded for each sample using a LSRFortessa machine (BD
Biosciences) equipped with a 488 nm blue laser. The data was
analyzed with FlowJo software (TreeStar Inc., USA).
Membrane colocalization : HeLa cells were plated at a density of
15000 cells per well, in an ibidi chamber slide. The following day, Cy3-
labeled DNA nanostructures were added to cells at the desired
concentrations and incubated at 37 8C for 20 minutes. The cells were
washed three times with media to remove adherent non-internalized
DNA. To stain cell membranes, a solution of CellMask Green (1 )
was added to cells and incubated 37 8C for 15 minutes followed by
washing with fresh media prior to remove excess dye. Imaging was
achieved using laser excitation at 488 nm (CellMask Green channel)
and 555 nm (Cy3 channel). Co-locolization analysis was accomplished
using the Coloc 2 plug-in of Fiji, a platform of ImageJ (NIH, USA).[32]
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